Delivery Order SPE2DB24D2010-SPE2DB25FAANB
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,248.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for REXULTI 1 mg tablets (30-count packages) with an ultimate completion date of July 24, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be...
- This is a $11,265.59 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication REXULTI 1 MG TABLET 30S. The contract has an ultimate completion date of April 17, 2025 and is not designated as a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product REXULTI 1 MG TABLET 30S. The contract, valued at $1,436.77, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $111,754.45 to AmerisourceBergen Drug Corp for the supply of REXULTI 2 mg tablets (30-count units) under a firm fixed price arrangement. The award, issued on July 21, 2025, with completion scheduled for July 22, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. Performance will...
- This is a $25,980.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the prescription medication REXULTI 1 MG TABLET 30S. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant...
- This is a $6,733.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the supply of REXULTI 1 MG TABLET 30S, a medication, with a performance period ending on July 10, 2025. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide REXULTI 2 mg tablets. The $3,234.78 contract has an ultimate completion date of April 1, 2024. This award is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
- This is a $2,820.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the antipsychotic medication REXULTI 1 MG TABLET 30S. The order has a performance period ending on June 24, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
- The U.S. Defense Logistics Agency (DLA) awarded a $6,495.49 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 1 mg REXULTI tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies in support of military healthcare programs. The contract does not have a set-aside designation and is expected to...
- The U.S. Defense Logistics Agency (DLA) awarded a $15,280.64 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a performance period through March 27, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...